EU left red faced as top US Dr Fauci hails AstraZeneca jab ‘likely a very good vaccine’

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

Experts from the National Institutes of Health (NIH) said the results of a recent US-based trial of the vaccine may have been drawn from “outdated information” that “provided an incomplete view of the efficacy data”.

But the White House’s chief coronavirus medical adviser Dr Anthony Fauci has insisted that it is “likely” that the vaccine is still “very good”.

Following a statement from the NIH, he claimed the agency’s data and safety monitoring board (DSMB) “got concerned” the data contained in AstraZeneca’s public statement “were somewhat outdated and might in fact be misleading a bit”.

But speaking to ABC News’ “Good Morning America” programme, Dr Fauci said: “This likely a very good vaccine.”

On Monday, AstraZeneca announced its clinical trial, which saw more than 30,000 people take part, revealed the vaccine to be 79 percent effective at preventing symptomatic coronavirus.

It was also found to be 100 percent effective at preventing severe illness and hospitalisation.

Medical experts dismissed concerns associated with blood clots, fears which had led to more than half of the current 27 EU member states to suspend use of the vaccine in their countries.

The scientists also said the vaccine was effective in all ages, including the over-65s.


Source: Read Full Article